Schedule 13G ownership disclosure
Ovid therapeutics, Inc.
Security class unavailable · CUSIP: 690469101
Event date: 2020-03-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,082,200
- Percent of class
- 9.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-21-000227
- Form type
- SC 13G
- Filer
- EcoR1 Capital Fund, L.P.
- CIK
- CIK 1567938
- Filed
- Mar 09, 2021
- Reporting period
- Mar 04, 2020
- Description
- Schedule 13G beneficial ownership